01-Mar-2023 | Facts and Factors
According to Facts and Factors, the global blood clot retrieval devices market size was worth around USD 1.6 billion in 2022 and is predicted to grow to around USD 5.0 billion by 2030 with a compound annual growth rate (CAGR) of roughly 15.2% between 2023 and 2030.
The thrombectomy devices, also referred to as blood clot retrieval devices, assist in removing blood clots by widening the blood arteries. Devices to remove blood blockages from the brain are very helpful in these situations. Beeping could be caused by a brain cell that isn't getting enough blood, but thrombectomy devices can clear blood clots. During the forecast period, the market is anticipated to be driven by rising knowledge regarding the accessibility of these devices as well as their effectiveness and dependability.
Browse the full “Blood Clot Retrieval Devices Market Size, Share, Growth Analysis Report By Stroke (Ischemic Stroke (Blood Clot), Hemorrhagic Stroke (Rupturing of Arteries) and Transient Ischemic Attack), By Device (Mechanical Embolus Removal Devices, Penumbra Blood Clot Retrieval Devices, Stent Retrievers, Aspiration Devices, and Ultrasound Assisted Devices), Application (Coronary Arteries, Peripheral Arteries, and Cerebral Arteries), By End User (Hospitals, Diagnostic Centers, Clinics and Ambulatory Surgical Centers), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 – 2030" report at https://www.fnfresearch.com/blood-clot-retrieval-devices-market
The main factor propelling the global blood clot retrieval devices market's growth is the increase in ischemic stroke, hemorrhagic stroke, and transient ischemic attack cases as a result of living a sedentary and unhealthy lifestyle. The market is also expected to expand as a result of favorable reimbursement policies, a rise in the demand for minimally invasive procedures, and an increase in the frequency of strokes among the aged. The growing awareness of acute ischemic stroke and its prevalence, as well as the demand for minimally invasive procedures, are all adding factors to the devices' rising acceptance on a worldwide scale.
According to data released by the American Stroke Association, it was estimated that there are over 690,000 ischemic strokes reported yearly in the United States. The risk of postoperative complications, the high cost of the surgery, the shortage of skilled workers and infrastructure, and the strict government rules governing the safety and effectiveness of blood clot retrieval devices all serve as obstacles to the blood clot retrieval devices industry's growth. It is anticipated that continuing research and development efforts on blood clot retrieval devices will open up new market opportunities.
Segmental Overview:
The global blood clot retrieval devices market is segmented based on stroke, device, application, end user, and region.
Based on the application, the global market is bifurcated into coronary arteries, peripheral arteries, and cerebral arteries. Coronary arteries are expected to dominate the market during the forecast period.
Based on the stroke, the global market is bifurcated into ischemic stroke (blood clot), hemorrhagic stroke (rupturing of arteries), and transient ischemic attack.
Based on the device, the global blood clot retrieval devices industry is segmented into mechanical embolus removal devices, penumbra blood clot retrieval devices, stent retrievers, aspiration devices, and ultrasound-assisted devices.
Based on the end user, the market is bifurcated into hospitals, diagnostic centers, clinics, and ambulatory surgical centers. The hospital segment is expected to dominate the market during the forecast period. As patients choose hospitals over all other treatment options, the hospital sector will have a larger market share in terms of revenue as compared to all other end users. The capacity to access all facilities under one roof will spur market expansion.
The most practical location for surgical procedures requiring the use of blood clot retrieval equipment is a hospital. This segment is anticipated to be in higher demand than all other available segments in every country in the world. On the other hand, blood clot retrieval devices are anticipated to be in high demand among diagnostic facilities and clinics for both disease detection and treatment. Hospitals have a much larger setup than the other total end-user segment, so during the forecast period, the segment will grow at a high compound annual growth rate.
Regional Overview:
The Asia Pacific market is expected to grow faster than the European and North American regions because these regions have many policies and governments are investing heavily to provide better healthcare services to their citizens. The Asia Pacific region will grow rapidly because the government is constantly working to improve people's living conditions. The healthcare industry is making success and is going through a major transformation in nations like China, India, and Australia.
The market is expanding primarily as a result of an increase in the number of acquisitions in the medical industry and altering governmental regulations. In these developing countries, labor is inexpensive and raw materials are readily accessible at lower prices. These two elements help developing economies thrive. The business is moving to develop economies for growth to provide better medical facilities and for the company based in developed economies to find better markets for expansion.
Report Scope
Report Attribute |
Details |
Market Size in 2022 |
USD 1.6 Billion |
Projected Market Size in 2030 |
USD 5 Billion |
CAGR Growth Rate |
15.2% CAGR |
Base Year |
2022 |
Forecast Years |
2023-2030 |
Key Market Players |
Inari Medical, Medtronic, AKURA MEDICAL INC., Penumbra Inc., Boston Scientific Corporation, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO. LTD., Terumo Corporation, Phenox GmbH, Shockwave Medical Inc., Cardinal Health, AngioDynamics, Johnson and Johnson, Bayer AG, Argon Medical Devices, Teleflex Incorporated, and others. |
Key Segment |
By Stroke, Device, Application, End User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Landscape:
The global blood clot retrieval devices market is dominated by players like Inari Medical, Medtronic, AKURA MEDICAL INC., Penumbra, Inc., Boston Scientific Corporation, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., Terumo Corporation, Phenox GmbH, Shockwave Medical Inc., Cardinal Health, AngioDynamics, Johnson and Johnson, Bayer AG, Argon Medical Devices and Teleflex Incorporated among others.
Recent Development:
- In February 2022, Innova Vascular, Inc. and Cardiovascular Systems, Inc. (CSI) collaborated on developing a complete range of thrombectomy devices, according to CSI. The company claims that CSI plans to purchase and sell novel thrombectomy devices from Innova that are intended to treat peripheral vascular diseases, such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
- In June 2022, the first patient in NeuroVasc Technologies, Inc.'s US IDE Clinical Study, ENVI RCT - NeuroVasc EnviTM-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke, has been successfully treated. The NeuroVasc ENVITM-SR, a stent-retriever designed for the treatment of acute ischemic stroke to reduce disability by removing blood clots in patients with stroke due to large vessel occlusion, will be the subject of this study to assess its safety and effectiveness.
The global blood clot retrieval devices market is segmented as follows:
By Stroke Segment Analysis
- Ischemic Stroke (Blood Clot)
- Hemorrhagic Stroke (Rupturing of Arteries)
- Transient Ischemic Attack
By Device
- Mechanical Embolus Removal Devices
- Penumbra Blood Clot Retrieval Devices
- Stent Retrievers
- Aspiration Device
- Ultrasound Assisted Devices
By Application
- Coronary Arteries
- Peripheral Arteries
- Cerebral Arteries
By End User
- Hospitals
- Diagnostic Centers
- Clinics
- Ambulatory Surgical Centers
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com
